Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemia.
Journal of internal medicine(2023)
Abstract
VEN combined with HMA was effective with R/R AML patients, and the response to treatment was associated with genetic characteristics.
MoreTranslated text
Key words
genetic characteristics,hypomethylating agents,relapsed or refractory AML,venetoclax
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined